| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.4B | $1.4B | $6.8B | $6.3B | $5.0B | $1.4B | $6.6B |
| Cost of Revenue | $1.2B | $1.1B | $1.1B | $5.2B | $5.0B | $3.9B | $1.2B | $1.1B |
| Gross Profit | $0.9B | $1.2B | $1.3B | $1.6B | $1.4B | $1.1B | $1.1B | $2.0B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $0.8B | $0.6B | $1.3B | $0.7B | $0.6B | $0.5B | $0.5B | $0.7B |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $-0.0B | $-0.0B | $-0.0B | $0.6B | $0.6B | $0.2B | $-0.3B | $0.1B |
| EPS (Basic) | $-0.31 | $-0.05 | $-0.12 | $3.72 | $3.69 | $1.33 | $-1.94 | $0.83 |
| EPS (Diluted) | $-0.31 | $-0.05 | $-0.12 | $3.65 | $3.60 | $1.32 | $-1.94 | $0.81 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.4B | $7.5B | $8.3B | $7.6B | $7.5B | $7.1B | $7.3B | $7.4B |
| Current Assets | $3.0B | $3.0B | $3.8B | $3.2B | $3.3B | $2.6B | $2.8B | $3.3B |
| Cash & Equivalents | $0.7B | $0.7B | $1.2B | $1.1B | $1.5B | $1.1B | $0.9B | $1.2B |
| Total Liabilities | $7.1B | $6.9B | $7.5B | $6.5B | $6.5B | $6.3B | $6.6B | $6.3B |
| Current Liabilities | $1.7B | $1.8B | $2.5B | $1.9B | $1.9B | $1.4B | $1.5B | $1.7B |
| Stockholders' Equity | $0.3B | $0.6B | $0.7B | $1.1B | $1.1B | $0.8B | $0.7B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $-0.6B | $0.6B | $0.8B | $0.8B | $0.8B | $0.7B | $1.1B |
| Investing Cash Flow | $-0.2B | $-0.4B | $-0.2B | $-0.3B | $0.2B | $-0.2B | $-0.5B | $-0.5B |
| Capital Expenditures | $0.2B | $0.4B | $0.4B | $0.3B | $0.3B | $0.3B | $0.5B | $0.5B |
| Financing Cash Flow | $-0.1B | $-0.0B | $0.2B | $-0.7B | $-0.6B | $-0.4B | $-0.4B | $-1.0B |